Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$327.48 USD

327.48
408,609

-3.64 (-1.10%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $327.85 +0.37 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (212 out of 249)

Industry: Medical - HMOs

Better trading starts here.

Zacks News

Molina Healthcare to Sell MMS Unit for Business Streamlining

Molina Healthcare's (MOH) impending sale of its unit is in line with its business restructuring initiatives.

    UnitedHeathcare Arm Gets Charge of Kansas Medicaid Program

    The State of Kansas picks UnitedHealth Group (UNH) arm for administering the statewide Medicaid Program.

      Molina Healthcare Hits 52 Week High: Is Further Upside Left?

      Molina Healthcare's (MOH) receipt of Florida Medicaid contract and a clearer visibility on its turnaround initiatives appear to appreciate its stock price.

        Aetna Arm Secures Contract for its Kansas Medicaid Program

        The State of Kansas awards Medicaid managed care contract to a subsidiary of Aetna (AET) for providing better health care to the Medicaid members.

          Molina Healthcare Clinches Medicaid Contracts in Florida

          Molina Healthcare's (MOH) unit wins Medicaid Managed Care contracts from the Florida Agency.

            Molina Healthcare (MOH) Up 4.3% Since Earnings Report: Can It Continue?

            Molina Healthcare (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

              Centene Corporation (CNC) Looks Good: Stock Adds 5% in Session

              Centene Corporation (CNC) shares rose 5% in the last trading session, amid huge volumes.

                Molina Healthcare (MOH) Tops Q1 Earnings, Updates '18 View

                Bottom-line growth plus lower expenses as well as medical care cost drive Molina Healthcare's (MOH) first-quarter results.

                  Will Higher Medicare Revenues Aid Aetna (AET) Q1 Earnings?

                  Aetna (AET) Q1 earnings should benefit from growth in its Medicare business and a lower tax rate, partly offset by a decline in revenues.

                    HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?

                    HCA Healthcare (HCA) Q1 results should see an upside from flu-related activity and lower taxes, partly offset by pressure on volumes.

                      Anthem, Inc. (ANTM) Jumps: Stock Rises 6.2%

                      Anthem (ANTM) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

                        Zacks Premium Research headshot

                        Can Government Business Drive Centene's (CNC) Q1 Earnings?

                        Centene's (CNC) first quarter 2018 results are likely to benefit from Medicaid expansion as well as rising participation in exchanges.

                          UnitedHealth (UNH) Q1 Earnings & Revenues Top, View Lifted

                          UnitedHealth (UNH) Q1 earnings reflect double-digit growth across each business line.

                            Will UnitedHealth (UNH) Q1 Earnings Buoy on Revenue Growth?

                            UnitedHealth's (UNH) Q1 earnings should see an upside from revenue growth at both its segments - Optum and UnitedHealthcare.

                              Molina Healthcare (MOH) Tops on Q4 Earnings, Issues '18 View

                              Restructuring costs and impairment loss affect Molina Healthcare's (MOH) fourth-quarter results.

                                4 Reasons Why You Should Buy Accuray (ARAY) Stock Right Now

                                Accuray (ARAY) rides high on its Radixact platform and latest software overhaul.

                                  PerkinElmer Hits 52-Week High: What's Driving the Stock?

                                  PerkinElmer's (PKI) shares hit a new 52-week high on the back of broad product spectrum and acquisition-led growth.

                                    CVS Health Grows on Pharmacy Services, Retail Remains a Drag

                                    CVS Health's (CVS) strong Pharmacy Services business continues to gain from a sturdy Specialty Pharmacy. However, its highly competitive retail pharmacy business raises concern.

                                      Boston Scientific's Positive SCS Trial Aids Neuromodulation

                                      Boston Scientific's (BSX) WHISPER RCT data demonstrates that sub-perception and paresthesia-based SCS therapies deliver superior results when applied as a combo regimen.

                                        IDEXX Launches Catalyst SDMA for Veterinary Renal Disorder

                                        IDEXX Laboratories (IDXX) already puts its Catalyst SDMA Test to use for hundreds of medical practices across the United States.

                                          Boston Scientific Fortifies Pain Therapy Arm With FDA Nod

                                          Boston Scientific (BSX) claims its Spectra WaveWriter Spinal Cord Stimulator System to combine both paresthesia-based and sub-perception therapies to target a specific area of pain.

                                            Sejuti Banerjea headshot

                                            5 HMO Stocks to Continue Rewarding Investors

                                            Here are five Buy-rated HMO stocks that should be in your portfolio.

                                              Abaxis' Product Line Expansion Aids Growth, Rivalry Rife

                                              Abaxis' (ABAX) growing portfolio of rapid test menu and a strong performance in Veterinary consumables drive growth. Intense competition in both the Medical and Veterinary markets is a concern.

                                                Stryker (SYK) Posts Upbeat Preliminary Sales Figure for Q4

                                                Stryker Corporation's (SYK) fourth quarter and 2017 preliminary net sales figures are encouraging, courtesy of balanced revenue growth in all business segments.

                                                  Teladoc Provides Strong Preliminary Results & 2018 Outlook

                                                  Teladoc's (TDOC) impressive fourth-quarter preliminary results and 2018 guidance reflects the company's solid business growth.